Tinurilimab | m-entrepreneurship.com

Product Name :
Tinurilimab

Search keywords :
Tinurilimab

drugId :
null

Target Vo:
Carcinoembryonic antigen related cell adhesion molecule 6

Target Vo Short Name :
CEACAM6

Moa_Name:
Carcinoembryonic antigen related cell adhesion molecule 6 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
German Cancer Research Center (Dkfz)

Active Company_Name :
Bayer AG

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Brentuximab custom synthesis
Phospho-FAK (Tyr576) Rabbit mAb web
LIN28A Antibody (YA711): LIN28A Antibody (YA711) is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to LIN28A (2C1). It can be used for WB assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts